摘要
本论文从治疗2型糖尿病药物应用现状出发,通过对2型糖尿病病理的认识,新发现的主要受体和相关药靶等方面进行分析。指出随着对糖尿病认识的深入发展,治疗糖尿病创新药物研究的发展趋势也发生了相应的变化,就是从局部治疗到全身综合考虑,从药物外部直接地干预到增强自身调节功能。为治疗2-型糖尿病药物发展指明了方向。
Starting from the treatment of drug in curing type 2-diabetes mellitus（DM-2） now, this essay mainly analyzes the pathogenesis of DM-2, the receptors and targets in curing DM-2. Following the deep recognition of DM-2, the develop tendency of new drug study in curring DM-2 changes corresponding. That is treatment from part to all over the body,new drug from direct intervention to enhance self regulation function. From these , the develop tendency and direction of new drug study in curring DM-2 are pointed out.
出处
《医学与哲学（B）》
2009年第2期58-59,共2页
Medicine & Philosophy(B)
关键词
2型糖尿病
受体
药靶
活性先导化合物
type 2-diabetes mellitus, receptor, target, active lead compound
